title: Safety and immunogenicity of a five-component acellular pertussis vaccine with varying antigen quantities.
authors.affiliation: Department of Pediatrics, Dalhousie University, Halifax, Nova Scotia, Canada.
authors.forename: S A
authors.initials: SA
authors.lastname: Halperin
authors.forename: L
authors.initials: L
authors.lastname: Barreto
authors.forename: B J
authors.initials: BJ
authors.lastname: Eastwood
authors.forename: B
authors.initials: B
authors.lastname: Law
authors.forename: E A
authors.initials: EA
authors.lastname: Roberts
mesh_terms: D000907:Antibodies, Bacterial / Q000097:blood; D000942:Antigens, Bacterial / Q000009:adverse effects / Q000276:immunology; D001886:Bordetella pertussis / Q000276:immunology*; D005260:Female; D010861:Fimbriae, Bacterial / Q000276:immunology; D006388:Hemagglutinins / Q000009:adverse effects / Q000276:immunology; D006801:Humans; D007223:Infant; D008297:Male; D010567:Pertussis Vaccine / Q000009:adverse effects / Q000276:immunology*; D014121:Toxoids / Q000009:adverse effects / Q000276:immunology; D018074:Vaccines, Conjugate / Q000009:adverse effects / Q000276:immunology
chemical_list: D000907:Antibodies, Bacterial; D000942:Antigens, Bacterial; D006388:Hemagglutinins; D010567:Pertussis Vaccine; D014121:Toxoids; D018074:Vaccines, Conjugate; C051093:pertussis toxoid